• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    BMS` Biologic Emplicti (Elotuzumab) Receives Approval in the U.S.

    FDA

    Indapta Therapeutics Announces New Preclinical Data for Proprietary G-NK Cells

    BUSINESSWIRE

    Bristol Myers Empliciti (Elotuzumab) Receives Supplemental Approval in US

    FDA

    Bristol-Myers, AbbVie`s multiple myeloma drug wins second EU nod as part of triple regimen

    ENDPTS

    Empliciti combo bags EU approval for multiple myeloma

    PHARMA TIMES

    EC OKs expanded label for Bristol-Myers` Empliciti

    SEEKINGALPHA

    J&J eyes Darzalex convenience, safety boost with subcutaneous win

    FIERCE PHARMA

    BMY`s to Present New Data on 20 Types Cancer from Across its Oncology Portfolio

    PRESS RELEASE

    Bristol Myers Squibb` Biological Empliciti(Elotuzumab) Receives Supplemental Approval in US

    FDA

    US approves new use for BMS’ Empliciti

    PHARMA TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.